Dilato and BP will be there until the company is bought by a major.
The only way I can see Dilato reducing is to help get a strategic partner set.
It's a publicly company's responsibility to extract the highest value for its assets/stock.
I believe an OTC listing would help PO3 truly reflect the value of its technology in its market cap.
Technically Speaking, page-633
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PO3 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.078M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| PO3 (ASX) Chart |
Day chart unavailable
